BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Okajima W, Komatsu S, Ichikawa D, Miyamae M, Ohashi T, Imamura T, Kiuchi J, Nishibeppu K, Arita T, Konishi H, Shiozaki A, Morimura R, Ikoma H, Okamoto K, Otsuji E. Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids. World J Gastroenterol 2017; 23(31): 5650-5668 [PMID: 28883691 DOI: 10.3748/wjg.v23.i31.5650]
URL: https://www.wjgnet.com/1948-5182/full/v23/i31/5650.htm
Number Citing Articles
1
Guo Long, Tongdi Fang, Wenxin Su, Xingyu Mi, LeDu Zhou. The prognostic value of postoperative circulating cell-free DNA in operable hepatocellular carcinomaScandinavian Journal of Gastroenterology 2020; 55(12): 1441 doi: 10.1080/00365521.2020.1839127
2
Lucas Trevisan França de Lima, Daniel Broszczak, Xi Zhang, Kim Bridle, Darrell Crawford, Chamindie Punyadeera. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinomaBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(2): 188451 doi: 10.1016/j.bbcan.2020.188451
3
Annarita Perillo, Mohamed Vincenzo Agbaje Olufemi, Jacopo De Robbio, Rossella Margherita Mancuso, Anna Roscigno, Maddalena Tirozzi, Ida Rosalia Scognamiglio. Liquid biopsy in NSCLC: a new challenge in radiation therapyExploration of Targeted Anti-tumor Therapy 2021;  doi: 10.37349/etat.2021.00038
4
Lingli Sun, Yuanlong Zhang, Wenji Zhang, Xingfei Lai, Qiuhua Li, Lingyun Zhang, Shili Sun. Green tea and black tea inhibit proliferation and migration of HepG2 cells via the PI3K/Akt and MMPs signalling pathwayBiomedicine & Pharmacotherapy 2020; 125: 109893 doi: 10.1016/j.biopha.2020.109893
5
Michihiro Kudou, Toshiyuki Kosuga, Eigo Otsuji. Artificial intelligence in gastrointestinal cancer: Recent advances and future perspectivesArtificial Intelligence in Gastroenterology 2020; 1(4): 71-85 doi: 10.35712/aig.v1.i4.71
6
Jelena Mann, Helen L Reeves, Ariel E Feldstein. Liquid biopsy for liver diseasesGut 2018; 67(12): 2204 doi: 10.1136/gutjnl-2017-315846
7
Marianna Alunni-Fabbroni, Kerstin Rönsch, Thomas Huber, Clemens C. Cyran, Max Seidensticker, Julia Mayerle, Maciej Pech, Bristi Basu, Chris Verslype, Julia Benckert, Peter Malfertheiner, Jens Ricke. Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trialJournal of Translational Medicine 2019; 17(1) doi: 10.1186/s12967-019-2079-9
8
Bo Kong, Helmut Friess. Translational Pancreatic Cancer ResearchMolecular and Translational Medicine 2020; : 97 doi: 10.1007/978-3-030-49476-6_6
9
Feifei Wei, Liang Yang, Dandan Jiang, Min Pan, Guiyan Tang, Mingyue Huang, Jing Zhang. Long noncoding RNA DUXAP8 contributes to the progression of hepatocellular carcinoma via regulating miR‐422a/PDK2 axisCancer Medicine 2020; 9(7): 2480 doi: 10.1002/cam4.2861
10
Yang Zhang, Yan Yang, Yi Zhang, Zhisu Liu. lncRNA ST8SIA6‑AS1 facilitates proliferation and invasion in liver cancer by regulating miR‑142‑3pExperimental and Therapeutic Medicine 2021; 22(6) doi: 10.3892/etm.2021.10783
11
I. F. Kustova, A. S. Makarova, N. L. Lazarevich. Potential of the use of methylation biomarkers for diagnostics and prognosis of hepatocellular carcinoma in liquid biopsyAdvances in molecular oncology 2019; 5(4): 8 doi: 10.17650/2313-805X-2018-5-4-8-19
12
Atsunori Tsuchiya, Masahiro Ogawa, Takayuki Watanabe, Suguru Takeuchi, Yuichi Kojima, Yusuke Watanabe, Naruhiro Kimura, Kazunao Hayashi, Junji Yokoyama, Shuji Terai. Diverse perspectives to address for the future treatment of heterogeneous hepatocellular carcinomaHeliyon 2019; 5(3): e01325 doi: 10.1016/j.heliyon.2019.e01325
13
Defeng Kong, Wen Zhang, Zhenrong Yang, Guoliang Li, Shujun Cheng, Kaitai Zhang, Lin Feng. Correlation between PD-L1 expression ON CTCs and prognosis of patients with cancer: a systematic review and meta-analysisOncoImmunology 2021; 10(1) doi: 10.1080/2162402X.2021.1938476
14
Ning Li, Ling Li, Yongshun Chen. The Identification of Core Gene Expression Signature in Hepatocellular CarcinomaOxidative Medicine and Cellular Longevity 2018; 2018: 1 doi: 10.1155/2018/3478305
15
Liang-Chun Yin, Zhen-Chao Luo, Yan-Xin Gao, Yang Li, Qing Peng, Yi Gao. Twist Expression in Circulating Hepatocellular Carcinoma Cells Predicts Metastasis and PrognosesBioMed Research International 2018; 2018: 1 doi: 10.1155/2018/3789613
16
Víctor Amado, Sandra González-Rubio, Javier Zamora, Rafael Alejandre, María Lola Espejo-Cruz, Clara Linares, Marina Sánchez-Frías, Gema García-Jurado, José Luis Montero, Rubén Ciria, Manuel Rodríguez-Perálvarez, Gustavo Ferrín, Manuel De la Mata. Clearance of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Surgical Resection or Liver TransplantationCancers 2021; 13(10): 2476 doi: 10.3390/cancers13102476
17
Hugo A. Barrera-Saldaña, Luis E. Fernández-Garza, Silvia A. Barrera-Barrera. Liquid biopsy in chronic liver diseaseAnnals of Hepatology 2021; 20: 100197 doi: 10.1016/j.aohep.2020.03.008
18
Gurjot Singh, Eric M Yoshida, Sahaj Rathi, Vladimir Marquez, Peter Kim, Siegfried R Erb, Baljinder S Salh. Biomarkers for hepatocellular cancerWorld Journal of Hepatology 2020; 12(9): 558-573 doi: 10.4254/wjh.v12.i9.558
19
Sinisa Bratulic, Francesco Gatto, Jens Nielsen. The Translational Status of Cancer Liquid BiopsiesRegenerative Engineering and Translational Medicine 2021; 7(3): 312 doi: 10.1007/s40883-019-00141-2
20
Tudor Mocan, André L. Simão, Rui E. Castro, Cecília M. P. Rodrigues, Artur Słomka, Bingduo Wang, Christian Strassburg, Aliona Wöhler, Arnulf G. Willms, Miroslaw Kornek. Liquid Biopsies in Hepatocellular Carcinoma: Are We Winning?Journal of Clinical Medicine 2020; 9(5): 1541 doi: 10.3390/jcm9051541
21
Qi Zhang, Yu Lou, Xue-Li Bai, Ting-Bo Liang. Intratumoral heterogeneity of hepatocellular carcinoma: From single-cell to population-based studiesWorld Journal of Gastroenterology 2020; 26(26): 3720-3736 doi: 10.3748/wjg.v26.i26.3720
22
Sally Temraz, Rihab Nasr, Deborah Mukherji, Firas Kreidieh, Ali Shamseddine. Liquid biopsy derived circulating tumor cells and circulating tumor DNA as novel biomarkers in hepatocellular carcinomaExpert Review of Molecular Diagnostics 2022; : 1 doi: 10.1080/14737159.2022.2094706
23
Shucai Xie, Xili Jiang, Jianquan Zhang, Shaowei Xie, Yongyong Hua, Rui Wang, Yijun Yang. Identification of significant gene and pathways involved in HBV-related hepatocellular carcinoma by bioinformatics analysisPeerJ 2019; 7: e7408 doi: 10.7717/peerj.7408
24
July Rodríguez, Jenny Avila, Christian Rolfo, Alejandro Ruíz-Patiño, Alessandro Russo, Luisa Ricaurte, Camila Ordóñez-Reyes, Oscar Arrieta, Zyanya Lucia Zatarain-Barrón, Gonzalo Recondo, Andrés F. Cardona. When Tissue is an Issue the Liquid Biopsy is Nonissue: A ReviewOncology and Therapy 2021; 9(1): 89 doi: 10.1007/s40487-021-00144-6
25
Matthias Pinter, Markus Peck-Radosavljevic. Review article: systemic treatment of hepatocellular carcinomaAlimentary Pharmacology & Therapeutics 2018; 48(6): 598 doi: 10.1111/apt.14913
26
Qianwei Ye, Sunbin Ling, Shusen Zheng, Xiao Xu. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNAMolecular Cancer 2019; 18(1) doi: 10.1186/s12943-019-1043-x
27
Joseph C. Ahn, Pai‐Chi Teng, Pin‐Jung Chen, Edwin Posadas, Hsian‐Rong Tseng, Shelly C. Lu, Ju Dong Yang. Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular CarcinomaHepatology 2021; 73(1): 422 doi: 10.1002/hep.31165
28
Matthias Ocker. Biomarkers for hepatocellular carcinoma: What’s new on the horizon?World Journal of Gastroenterology 2018; 24(35): 3974-3979 doi: 10.3748/wjg.v24.i35.3974
29
Andrea Casadei-Gardini, Orsi Giulia, Caputo Francesco, Ercolani Giorgio. Developments in predictive biomarkers for hepatocellular carcinoma therapyExpert Review of Anticancer Therapy 2020; 20(1): 63 doi: 10.1080/14737140.2020.1712198
30
Yi-Ping Hung, Yu-Yun Shao, Chiun Hsu, Chih-Hung Hsu, Jan-Mou Lee, Muh-Hwa Yang, Yee Chao. The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinomaJournal of the Formosan Medical Association 2021; 120(8): 1581 doi: 10.1016/j.jfma.2020.11.015
31
Matteo Canale, Paola Ulivi, Francesco Giuseppe Foschi, Emanuela Scarpi, Serena De Matteis, Gabriele Donati, Giorgio Ercolani, Mario Scartozzi, Luca Faloppi, Alessandro Passardi, Emiliano Tamburini, Martina Valgiusti, Giorgia Marisi, Giovanni Luca Frassineti, Andrea Casadei Gardini. Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinomaCritical Reviews in Oncology/Hematology 2018; 129: 44 doi: 10.1016/j.critrevonc.2018.06.017
32
Wen-Ying Yang, Lin-Fei Feng, Xiang Meng, Ran Chen, Wen-Hua Xu, Jun Hou, Tao Xu, Lei Zhang. Liquid biopsy in head and neck squamous cell carcinoma: circulating tumor cells, circulating tumor DNA, and exosomesExpert Review of Molecular Diagnostics 2020; 20(12): 1213 doi: 10.1080/14737159.2020.1855977
33
Yao Chen, Haifeng Xie, Ting Xie, Xunjun Yang, Yilin Pang, SongDao Ye. Elevated Expression of PDZD11 Is Associated With Poor Prognosis and Immune Infiltrates in Hepatocellular CarcinomaFrontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.669928
34
Ying-Hsiu Su, Amy K. Kim, Surbhi Jain. Liquid biopsies for hepatocellular carcinomaTranslational Research 2018; 201: 84 doi: 10.1016/j.trsl.2018.07.001
35
Ling Li, Huijia Zhao, Binyao Chen, Kang Huang, Zhuowen Hao, Zhipeng Fan, Gongpeng Sun, Jianguo Wu, Ning Li, Qifa Ye, Jiang Yue. Noninvasive Identification of Immune-Related Biomarkers in Hepatocellular CarcinomaJournal of Oncology 2019; 2019: 1 doi: 10.1155/2019/2531932
36
Filippo Pelizzaro, Romilda Cardin, Barbara Penzo, Elisa Pinto, Alessandro Vitale, Umberto Cillo, Francesco Paolo Russo, Fabio Farinati. Liquid Biopsy in Hepatocellular Carcinoma: Where Are We Now?Cancers 2021; 13(9): 2274 doi: 10.3390/cancers13092274
37
María Lola Espejo-Cruz, Sandra González-Rubio, Javier Zamora-Olaya, Víctor Amado-Torres, Rafael Alejandre, Marina Sánchez-Frías, Rubén Ciria, Manuel De la Mata, Manuel Rodríguez-Perálvarez, Gustavo Ferrín. Circulating Tumor Cells in Hepatocellular Carcinoma: A Comprehensive Review and Critical AppraisalInternational Journal of Molecular Sciences 2021; 22(23): 13073 doi: 10.3390/ijms222313073
38
Olorunseun O Ogunwobi, Trisheena Harricharran, Jeannette Huaman, Anna Galuza, Oluwatoyin Odumuwagun, Yin Tan, Grace X Ma, Minhhuyen T Nguyen. Mechanisms of hepatocellular carcinoma progressionWorld Journal of Gastroenterology 2019; 25(19): 2279-2293 doi: 10.3748/wjg.v25.i19.2279
39
Kewen He, Shaotong Zhang, Liang L. Shao, Jiani C. Yin, Xue Wu, Yang W. Shao, Shuanghu Yuan, Jinming Yu. Developing more sensitive genomic approaches to detect radioresponse in precision radiation oncology: From tissue DNA analysis to circulating tumor DNACancer Letters 2020; 472: 108 doi: 10.1016/j.canlet.2019.12.004
40
Rasha Elzehery, Narmin Effat, Reham El Farahaty, Raghda Elsayed Farag, Ekbal M Abo-Hashem, Rania Elhelaly. Circulating Cell-Free DNA and DNA Integrity as Molecular Diagnostic Tools in Hepatocellular CarcinomaAmerican Journal of Clinical Pathology 2022;  doi: 10.1093/ajcp/aqac037
41
Kai-Qian Zhou, Yun-Fan Sun, Jian-Wen Cheng, Min Du, Yuan Ji, Peng-Xiang Wang, Bo Hu, Wei Guo, Yang Gao, Yue Yin, Jun-Feng Huang, Jian Zhou, Jia Fan, Xin-Rong Yang. Effect of surgical margin on recurrence based on preoperative circulating tumor cell status in hepatocellular carcinomaeBioMedicine 2020; 62: 103107 doi: 10.1016/j.ebiom.2020.103107
42
Luciana Santos Pessoa, Manoela Heringer, Valéria Pereira Ferrer. ctDNA as a cancer biomarker: A broad overviewCritical Reviews in Oncology/Hematology 2020; 155: 103109 doi: 10.1016/j.critrevonc.2020.103109
43
Irun Bhan, Daniel A. Haber, Raymond T. Chung, David T. Ting. Hepatocellular CarcinomaMolecular and Translational Medicine 2019; : 125 doi: 10.1007/978-3-030-21540-8_7
44
Yurika Kotoh, Yutaka Suehiro, Issei Saeki, Tomomi Hoshida, Masaki Maeda, Takuya Iwamoto, Toshihiko Matsumoto, Isao Hidaka, Tsuyoshi Ishikawa, Taro Takami, Shingo Higaki, Ikuei Fujii, Chieko Suzuki, Yoshitaro Shindo, Yukio Tokumitsu, Hiroaki Nagano, Isao Sakaida, Takahiro Yamasaki. Novel Liquid Biopsy Test Based on a Sensitive Methylated SEPT9 Assay for Diagnosing Hepatocellular Carcinoma Hepatology Communications 2020; 4(3): 461 doi: 10.1002/hep4.1469
45
Mehrdad Ameri, Haniye Salimi, Sedigheh Eskandari, Navid Nezafat. Identification of potential biomarkers in hepatocellular carcinoma: A network-based approachInformatics in Medicine Unlocked 2022; 28: 100864 doi: 10.1016/j.imu.2022.100864
46
Eiichiro Suzuki, Tetsuhiro Chiba, Naoya Kato. Biomarkers in Cancer Therapy2019; : 87 doi: 10.1007/978-981-13-7295-7_8
47
Qiong Luo, Chunming Wang, Bangjian Peng, Xiaoyu Pu, Lei Cai, Hangyu Liao, Kunling Chen, Cheng Zhang, Yuan Cheng, Mingxin Pan. Circulating Tumor-Cell-Associated White Blood Cell Clusters in Peripheral Blood Indicate Poor Prognosis in Patients With Hepatocellular CarcinomaFrontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01758
48
Francesca Carissimi, Matteo Nazzareno Barbaglia, Livia Salmi, Cristina Ciulli, Linda Roccamatisi, Giuseppe Cordaro, Venkata Ramana Mallela, Rosalba Minisini, Biagio Eugenio Leone, Matteo Donadon, Guido Torzilli, Mario Pirisi, Fabrizio Romano, Simone Famularo. Finding the seed of recurrence: Hepatocellular carcinoma circulating tumor cells and their potential to drive the surgical treatmentWorld Journal of Gastrointestinal Surgery 2021; 13(9): 967-978 doi: 10.4240/wjgs.v13.i9.967